NimBio’s Post

We are thrilled to share that our portfolio company NimBio won the EIT Health Open Innovation Programme for inflammatory bowel diseases (IBD)! NimBio is at the forefront of healthcare innovation, developing cutting-edge technology to monitor inflammatory biomarkers. This breakthrough allows for the effortless and non-invasive early detection of flares, revolutionizing the management of Inflammatory Bowel Disease (IBD). Winning this competition marks a significant milestone, opening doors to collaborate with EIT Health, KU Leuven, and Takeda. These collaboration efforts will make effortless, non-invasive early flare detection a reality for millions of IBD patients, improving their quality of life and healthcare outcomes. This achievement is a testament to our NimBio’s dedication and the impact of their technology. Here is to wishing them luck on their great journey!  #NimBio #EITHealth #IBD #HealthInnovation #Winner #Gratitude